-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ff7zKXB1Z22HwmDmlb4VIYG9o2aaplo8Kqkcco+fkzsQDq/TK7JwnjOgBUSnTng/ vobWt1S0q2yQur+WE3CNpQ== 0001209191-07-006906.txt : 20070201 0001209191-07-006906.hdr.sgml : 20070201 20070201192247 ACCESSION NUMBER: 0001209191-07-006906 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070201 DATE AS OF CHANGE: 20070201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lundberg Peter CENTRAL INDEX KEY: 0001321344 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07573308 BUSINESS ADDRESS: BUSINESS PHONE: (510)670-9300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD. CITY: HAYWARD STATE: CA ZIP: 94545 4/A 1 bsf26824_bsf16pl.xml MAIN DOCUMENT DESCRIPTION X0202 4/A 2007-01-26 2007-01-30 1 0000913275 Solexa, Inc. SLXA 0001321344 Lundberg Peter C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 VP and Chief Technical Officer Stock Option (Right to Buy) 6.11 2007-01-26 4 D 0 32500 0.00 D 2015-06-03 Common Stock 32500 0 D Stock Option (Right to Buy) 5.97 2007-01-26 4 D 0 27500 0.00 D 2015-09-06 Common Stock 27500 0 D Stock Option (Right to Buy) 8.60 2007-01-26 4 D 0 23750 0.00 D 2016-02-02 Common Stock 23750 0 D This option, which provided for vesting of 20% on the one year anniversary of March 10, 2005 and monthly thereafter over 48 months, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 11,180 shares at an exercise price of $17.76 per share. This option, which provided for vesting monthly and ratably over the 48 month period beginning on September 6, 2005, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 9,460 shares at an exercise price of $17.35 per share. This option, which provided for vesting monthly and ratably over the 48 month period beginning on February 2, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 8,170 shares at an exercise price of $25.00 per share. /s/ Peter Lundberg, by Kathy San Roman, attorney-in-fact 2007-02-01 -----END PRIVACY-ENHANCED MESSAGE-----